Report : Europe Spirometer Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Handheld Spirometers, Table-top Spirometers, and Desktop Spirometers), Technology (Volume, Flow, and Peak Flow), and Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Others) 

At 11.2% CAGR, the Europe Spirometer Market is speculated to be worth US$ 532.15 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Europe spirometer market was valued at US$ 281.38 million in 2022 and is expected to reach US$ 532.15 million by 2028, registering an annual growth rate of 11.2% from 2022 to 2028. The increasing prevalence of respiratory diseases and rising preference of home care products are the critical factors attributed to the market expansion.

The higher prevalence of respiratory disorders is related to the decrease in the size of the upper airway lumen in the aging population. Lung diseases are among the most common medical conditions. Further, millions of people are suffering from various types of respiratory diseases across the region. Moreover, smoking, genetic factors, and infections are among the common factors responsible for respiratory diseases. Medical conditions such as asthma and chronic obstructive pulmonary disease (COPD), chronic bronchitis, cystic fibrosis, and lung cancer are significant public health burdens. With the increasing prevalence of smoking in developing countries and the aging population in high-income countries, the COPD prevalence is projected to rise over the next forty years. Patients suffering from respiratory disorders commonly experience difficulty in breathing. Further, early detection and diagnosis can help in treating the patients suffering from respiratory diseases and in such cases, spirometry is a crucial technology that assists in indulging in the severity of the infection and avoids misdiagnosis. Thus, with the increasing incidence of such respiratory diseases, the market is witnessing a positive growth.

On the contrary, unfavorable reimbursement scenario hurdles the growth of Europe spirometer market.

Based on type, the Europe spirometer market is segmented into handheld spirometers, table-top spirometers, and desktop spirometers. The table-top spirometers segment held 43.7% market share in 2022, amassing US$ 122.97 million. It is projected to garner US$ 226.34 million by 2028 to expand at 10.7% CAGR during 2022–2028.

The Europe spirometer market, by technology, is segmented into volume, flow, and peak flow. The flow segment held 47.9% market share in 2022, amassing US$ 134.77 million. It is projected to garner US$ 258.42 million by 2028 to expand at 11.5% CAGR during 2022–2028.

The Europe spirometer market, by application is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and others. With 39.4% share of the domain, the chronic obstructive pulmonary disease segment dominated the market in 2022. It accrued US$ 110.89 million in 2022 and is estimated to generate US$ 211.95 million by 2028 to grow at a CAGR of 11.4% over the forecast period.

Based on country, the Europe spirometer market is categorized into Germany, the UK, France, Italy, Spain, and the rest of Europe. Our regional analysis states that Germany captured 26.6% market share in 2022. It was assessed at US$ 74.91 million in 2022 and is likely to hit US$ 146.08 million by 2028, exhibiting a CAGR of 11.8% during the forecast period.

Key players dominating the Europe spirometer market are Baxter International Inc.; COSMED Srl; Depisteo LLC.; Henry Schein, Inc.; ICU Medical Inc.; NUVOAIR U.S, INC. (NUVOAIR AB); Teleflex Incorporated; and VYAIRE MEDICAL, INC among others.

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id:

Download Free PDF Brochure